Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Vaccines"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 389132
Tytuł:
Effect of maternal immunisation with multivalent vaccines containing inactivated poliovirus vaccine (IPV) on infant IPV immune response: A phase 4, multi-centre randomised trial.
Autorzy:
Grassly NC; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, UK. Electronic address: .
Andrews N; Statistics and Modelling Economics Department, United Kingdom Health Security Agency (UKHSA), UK.
Cooper G; National Institute of Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency, UK.
Stephens L; National Institute of Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency, UK.
Waight P; Immunisation and Countermeasures, National Infection Service, UKHSA, London, UK.
Jones CE; Centre for Neonatal and Paediatric Infection & Vaccine Institute, St George's, University of London, London, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton and National Institute for Health and Care Research (NIHR) Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Heath PT; Centre for Neonatal and Paediatric Infection & Vaccine Institute, St George's, University of London, London, UK; St George's University Hospitals NHS Foundation Trust, London, UK.
Calvert A; Centre for Neonatal and Paediatric Infection & Vaccine Institute, St George's, University of London, London, UK; St George's University Hospitals NHS Foundation Trust, London, UK.
Southern J; Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Martin J; National Institute of Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency, UK.
Miller E; Department of Infectious Disease Epidemiology, Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, Keppel St, London WC1E 7HT, UK.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2023 Feb 10; Vol. 41 (7), pp. 1299-1302. Date of Electronic Publication: 2023 Jan 21.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase IV; Journal Article
MeSH Terms:
Diphtheria-Tetanus-acellular Pertussis Vaccines*/adverse effects
Poliovirus*
Haemophilus Vaccines*
Pregnancy ; Humans ; Infant ; Female ; Child, Preschool ; Middle Aged ; Vaccines, Combined ; Poliovirus Vaccine, Inactivated/adverse effects ; Immunization, Secondary ; Diphtheria-Tetanus-Pertussis Vaccine ; Vaccination ; Bacterial Vaccines ; Antibodies, Bacterial
Czasopismo naukowe
Szczegóły
Tytuł:
Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations.
Autorzy:
Álvarez García FJ; Centro de Salud de Llanera, Asturias, Spain; Departamento de Medicina, Universidad de Oviedo, Oviedo, Spain. Electronic address: .
Cilleruelo Ortega MJ; Servicio de Pediatría, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain; Departamento de Pediatría, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain.
Álvarez Aldeán J; Servicio de Pediatría, Hospital Costa del Sol, Marbella, Málaga, Spain.
Garcés-Sánchez M; Centro de Salud Nazaret, Valencia, Spain; Área de Vacunas, FISABIO, Valencia, Spain.
Garrote Llanos E; Sección de Infectología, Hospital Universitario de Basurto, Bilbao, Spain; Facultad de Medicina, Universidad del País Vasco, UPV-EHU, Bilbao, Spain.
Iofrío de Arce A; Centro de Salud El Ranero, Murcia, Spain.
Montesdeoca Melián A; Equipo de Intervención, Las Palmas de Gran Canaria, Spain.
Navarro Gómez ML; Servicio de Pediatría, Hospital Universitario Gregorio Marañón, Madrid, Spain; Departamento de Pediatría, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
Pineda Solas V; Sección de Infectología Pediátrica, Hospital Universitario Parc Tauli-Sabadell, Sabadell, Barcelona, Spain; Universidad Autónoma de Barcelona, Barcelona, Spain.
Rivero Calle I; Sección de Pediatría Clínica, Infectológica y Traslacional, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, Spain; Grupo Genética, Vacunas, Infecciones y Pediatría (GENVIP), La Coruña, Spain.
Ruiz-Contreras J; Servicio de Pediatría, Hospital Universitario 12 de Octubre, Madrid, Spain; Departamento de Pediatría, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
Serrano Marchuet P; Equipo de Pediatría Territorial del Garraf, Barcelona, Spain.
Pokaż więcej
Corporate Authors:
en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP)
Źródło:
Anales de pediatria [An Pediatr (Engl Ed)] 2023 Jan; Vol. 98 (1), pp. 58.e1-58.e10.
Typ publikacji:
Journal Article
MeSH Terms:
Meningococcal Vaccines*
Meningococcal Infections*
COVID-19*
Rotavirus Vaccines*
Pregnancy ; Infant ; Adolescent ; Child ; Humans ; Infant, Newborn ; Female ; Immunization Schedule ; COVID-19 Vaccines ; Infant, Premature ; SARS-CoV-2 ; Bacterial Vaccines ; Vaccines, Combined
Czasopismo naukowe
Szczegóły
Tytuł:
Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022.
Autorzy:
Moro PL; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: .
Zhang B; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Ennulat C; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Harris M; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
McVey R; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Woody G; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Marquez P; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
McNeil MM; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Su JR; Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2023 Mar 10; Vol. 41 (11), pp. 1859-1863. Date of Electronic Publication: 2023 Jan 09.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Influenza Vaccines*/adverse effects
COVID-19*/prevention & control
Influenza, Human*/prevention & control
Humans ; United States/epidemiology ; Infant ; COVID-19 Vaccines/adverse effects ; Vaccines, Inactivated ; Adverse Drug Reaction Reporting Systems ; Seasons ; RNA, Messenger
Czasopismo naukowe
Szczegóły
Tytuł:
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Autorzy:
Tricou V; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland. Electronic address: .
Eyre S; Medical Operations, Synexus Merseyside Clinical Research Centre, Liverpool, L22 0LG Merseyside, UK.
Ramjee M; Synexus Lancashire Clinical Research Centre, Chorley, PR7 7NA Lancashire, UK.
Collini P; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, S10 2RX Sheffield, UK.
Mojares Z; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
Loeliger E; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
Mandaric S; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
Rauscher M; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
Brose M; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
Lefevre I; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
Folschweiller N; Takeda Pharmaceuticals International AG, 8152 Glattpark-Opfikon (Zurich), Switzerland.
Wallace D; Global Dengue Program, Takeda Vaccines, Inc., Boston, 02139 MA, USA.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2023 Feb 10; Vol. 41 (7), pp. 1398-1407. Date of Electronic Publication: 2023 Jan 19.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Dengue Vaccines*
Dengue Virus*
Viral Vaccines*
Hepatitis A*/prevention & control
Hepatitis A virus*
Dengue*/prevention & control
Adult ; Humans ; Vaccines, Combined/adverse effects ; Hepatitis A Antibodies ; Vaccines, Attenuated ; Double-Blind Method ; Hepatitis A Vaccines/adverse effects ; Immunogenicity, Vaccine ; Antibodies, Viral
Czasopismo naukowe
Szczegóły
Tytuł:
A Comprehensive Review of mRNA Vaccines.
Autorzy:
Gote V; Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Bolla PK; Department of Biomedical Engineering, College of Engineering, The University of Texas at El Paso, 500 W University Ave, El Paso, TX 79968, USA.
Kommineni N; Center for Biomedical Research, Population Council, New York, NY 10065, USA.
Butreddy A; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.
Nukala PK; College of Pharmacy and Health Sciences, St. John's University, 8000 Utopia Pkwy, Queens, NY 11439, USA.
Palakurthi SS; Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, TX 78363, USA.
Khan W; Natco Research Centre, NATCO Pharma Limited, Hyderabad 500018, India.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 31; Vol. 24 (3). Date of Electronic Publication: 2023 Jan 31.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/prevention & control
Nanoparticles*
Vaccines*
Humans ; Pandemics ; mRNA Vaccines ; Antigen-Presenting Cells ; COVID-19 Vaccines/genetics ; Vaccines, Synthetic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study.
Autorzy:
Kamal SM; Department of Internal Medicine, Prince Sattam Bin Abdulaziz University College of Medicine, Al-Kharj 16278, Saudi Arabia.
Naghib MM; Department of Internal Medicine, Prince Sattam Bin Abdulaziz University College of Medicine, Al-Kharj 16278, Saudi Arabia.
Daadour M; Department of Internal Medicine, Prince Sattam Bin Abdulaziz University College of Medicine, Al-Kharj 16278, Saudi Arabia.
Alsuliman MN; Department of Internal Medicine, Prince Sattam Bin Abdulaziz University College of Medicine, Al-Kharj 16278, Saudi Arabia.
Alanazi ZG; Department of Internal Medicine, Prince Sattam Bin Abdulaziz University College of Medicine, Al-Kharj 16278, Saudi Arabia.
Basalem AA; Department of Internal Medicine, Prince Sattam Bin Abdulaziz University College of Medicine, Al-Kharj 16278, Saudi Arabia.
Alaskar AM; Department of Internal Medicine, Prince Sattam Bin Abdulaziz University College of Medicine, Al-Kharj 16278, Saudi Arabia.
Saed K; Department of Internal Medicine, Prince Sattam Bin Abdulaziz University College of Medicine, Al-Kharj 16278, Saudi Arabia.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jan 24; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Vaccines*
Humans ; 2019-nCoV Vaccine mRNA-1273 ; BNT162 Vaccine ; COVID-19 Vaccines ; ChAdOx1 nCoV-19 ; Sand ; Longitudinal Studies ; Prospective Studies ; SARS-CoV-2/genetics ; mRNA Vaccines ; Antibodies, Viral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A survey of mechanisms underlying current and potential COVID-19 vaccines.
Autorzy:
Hebel C; Department of Immunology and Microbiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark.
Thomsen AR; Department of Immunology and Microbiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2023 Feb; Vol. 131 (2), pp. 37-60. Date of Electronic Publication: 2022 Dec 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/prevention & control
Viral Vaccines*
Vaccines*
Humans ; COVID-19 Vaccines ; SARS-CoV-2 ; Pandemics/prevention & control
Czasopismo naukowe
Szczegóły
Tytuł:
Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals?
Autorzy:
Sehrawat S; Department of Biological Sciences, Indian Institute of Science Education and Research Mohali, Sector 81, SAS Nagar Knowledge City, PO Manauli, Mohali 140306, Punjab, India. Electronic address: .
Osterrieder N; Institut für Virologie, Freie Universität Berlin, Robert-von-Ostertag-Str. 7-13, 14163 Berlin, Germany; Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, 5F, Block 1B, To Yuen Building, 31 To Yuen Street, Kowloon Tong, Hong Kong. Electronic address: .
Schmid DS; Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO, USA. Electronic address: .
Rouse BT; College of Veterinary Medicine, University of Tennessee Knoxville, TN 37996-0845, USA. Electronic address: .
Pokaż więcej
Źródło:
Microbes and infection [Microbes Infect] 2023 Jan-Feb; Vol. 25 (1-2), pp. 105078. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/prevention & control
Virus Diseases*
Viral Vaccines*/genetics
Animals ; Humans ; COVID-19 Vaccines/genetics ; Animals, Domestic ; Pandemics/prevention & control ; RNA, Messenger/genetics ; mRNA Vaccines
Czasopismo naukowe
Szczegóły
Tytuł:
The social and socio-political embeddedness of COVID-19 vaccination decision-making: A five-country qualitative interview study from Europe.
Autorzy:
Zimmermann BM; Institute for Biomedical Ethics, University of Basel, Basel, Switzerland; Institute of History and Ethics in Medicine, School of Social Sciences, TUM School of Medicine, Technical University of Munich, Munich, Germany. Electronic address: .
Paul KT; Department of Political Science & Research Platform Governance of Digital Practices (DigiGov), University of Vienna, Universitätsstraße 7, 1010 Wien, Austria. Electronic address: .
Araújo ER; Institute of Social Sciences, Research Center on Communication Studies, University of Minho, Gualtar, 4710-057 Braga, Portugal. Electronic address: .
Buyx A; Institute of History and Ethics in Medicine, School of Social Sciences, TUM School of Medicine, Technical University of Munich, Munich, Germany. Electronic address: .
Ferstl S; Department of Political Science & Research Platform Governance of Digital Practices (DigiGov), University of Vienna, Universitätsstraße 7, 1010 Wien, Austria. Electronic address: .
Fiske A; Institute of History and Ethics in Medicine, School of Social Sciences, TUM School of Medicine, Technical University of Munich, Munich, Germany. Electronic address: .
Kraus D; Department of Political Science & Research Platform Governance of Digital Practices (DigiGov), University of Vienna, Universitätsstraße 7, 1010 Wien, Austria. Electronic address: .
Marelli L; Department of Medical Biotechnology and Translational Medicine, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy; Life Sciences & Society Lab, Centre for Sociological Research, KU Leuven, Parkstraat 45, 3000 Leuven, Belgium. Electronic address: .
McLennan S; Institute of History and Ethics in Medicine, School of Social Sciences, TUM School of Medicine, Technical University of Munich, Munich, Germany. Electronic address: .
Porta V; Department of Experimental Oncology, IEO, Istituto Europeo di Oncologia IRCCS, Via Adamello 16, 20139 Milan, Italy. Electronic address: .
Prainsack B; Department of Political Science & Research Platform Governance of Digital Practices (DigiGov), University of Vienna, Universitätsstraße 7, 1010 Wien, Austria. Electronic address: .
Radhuber IM; Department of Political Science, University of Vienna, Universitätsstraße 7, 1010 Wien, Austria. Electronic address: .
Saxinger G; Department of Political Science, University of Vienna, Universitätsstraße 7, 1010 Wien, Austria Institute of Social Anthropology, University of Bern, Lerchenweg 36, 3012 Bern, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2023 Mar 17; Vol. 41 (12), pp. 2084-2092. Date of Electronic Publication: 2023 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/prevention & control
Vaccines*
Influenza Vaccines*
Humans ; COVID-19 Vaccines ; Vaccination ; Qualitative Research ; Europe
Czasopismo naukowe
Szczegóły
Tytuł:
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.
Autorzy:
Ford A; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: .
Hwang A; Angela Hwang Consulting, PO Box 6601, Albany, CA 94706, USA. Electronic address: .
Mo AX; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: .
Baqar S; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: .
Touchette N; Office of Global Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: .
Deal C; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: .
King D; Infectious Disease Health Challenge - Prevention, Wellcome Trust, London NW1 2BE, United Kingdom. Electronic address: .
Earle K; Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, PO Box 23350, Seattle, Washington 98102, USA. Electronic address: .
Giersing B; Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland. Electronic address: .
Dull P; Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, PO Box 23350, Seattle, Washington 98102, USA. Electronic address: .
Hall BF; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2023 Mar 10; Vol. 41 (11), pp. 1799-1807. Date of Electronic Publication: 2023 Feb 18.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/prevention & control
Vaccines*
Tuberculosis Vaccines*
Humans ; COVID-19 Vaccines ; Pandemics/prevention & control ; Immunization ; Immunization Programs
Czasopismo naukowe
Szczegóły
Tytuł:
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
Autorzy:
Tricou V; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Essink B; Meridian Clinical Research, Omaha, Nebraska, United States of America.
Ervin JE; Center for Pharmaceutical Research Inc, Kansas City, Missouri, United States of America.
Turner M; Advanced Clinical Research, Boise, Idaho, United States of America.
Escudero I; Takeda Vaccines Pte. Ltd., Singapore.
Rauscher M; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Brose M; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Lefevre I; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Borkowski A; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Wallace D; Takeda Vaccines Inc., Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Mar 08; Vol. 17 (3), pp. e0011124. Date of Electronic Publication: 2023 Mar 08 (Print Publication: 2023).
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Yellow Fever Vaccine*
Dengue Vaccines*
Dengue*
Yellow Fever*/prevention & control
Adult ; Humans ; Vaccines, Combined ; Antibodies, Viral ; Immunogenicity, Vaccine ; Vaccines, Attenuated
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines.
Autorzy:
Peletta A; Section of Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Rue Michel-Servet 1, 1221 Geneva, Switzerland. Electronic address: .
Lemoine C; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-les-Ouates, Switzerland. Electronic address: .
Courant T; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-les-Ouates, Switzerland. Electronic address: .
Collin N; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-les-Ouates, Switzerland. Electronic address: .
Borchard G; Section of Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Rue Michel-Servet 1, 1221 Geneva, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
Pharmacological research [Pharmacol Res] 2023 Mar; Vol. 189, pp. 106699. Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*
Vaccines*
Humans ; Adjuvants, Vaccine ; Pandemics ; Vaccination/methods ; Vaccines, Subunit ; Adjuvants, Immunologic
Czasopismo naukowe
Szczegóły
Tytuł:
An oral NoV-rAd5 vaccine with built-in dsRNA adjuvant elicits systemic immune responses in mice.
Autorzy:
Wang J; Department of Pathogenic Biology, Weifang Medical University, Weifang 261053, China; National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Ma Y; National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; School of Public Health, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China.
Li J; National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Peng R; National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Mao T; National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Sun X; National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Duan Z; National Institute for Viral Diseases Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2023 Mar; Vol. 116, pp. 109801. Date of Electronic Publication: 2023 Feb 11.
Typ publikacji:
Journal Article
MeSH Terms:
Viral Vaccines*
Adenovirus Vaccines*
Norovirus*/genetics
Humans ; Mice ; Animals ; Adenoviridae/genetics ; RNA, Double-Stranded ; Antibodies, Viral ; Vaccines, Synthetic ; Adjuvants, Immunologic/pharmacology ; Immunity, Mucosal ; Mice, Inbred BALB C
Czasopismo naukowe
Szczegóły
Tytuł:
A polymerase mechanism-based strategy constructing attenuated clones of enterovirus for vaccine vector development.
Autorzy:
Ji C; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
Zhang Y; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
Feng Y; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
Zhang X; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
Wang K; China Animal Health and Epidemiology Center, Qingdao, China.
Ma J; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
Pan Z; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China. Electronic address: .
Yao H; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
Pokaż więcej
Źródło:
Virology [Virology] 2023 Mar; Vol. 580, pp. 1-7. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Enterovirus*
Enterovirus Infections*
Enterovirus A, Human*
Vaccines*
Viral Vaccines*
Humans ; Clone Cells ; Vaccines, Attenuated
Czasopismo naukowe
Szczegóły
Tytuł:
Development of SYBR green RT-qPCR assay for titrating bivalent live infectious bronchitis vaccines.
Autorzy:
Yang H; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Tu K; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Zhao Y; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Sun L; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
Zhao J; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Electronic address: .
Zhang G; Key Laboratory of Animal Epidemiology of the Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of virological methods [J Virol Methods] 2023 Mar; Vol. 313, pp. 114675. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Viral Vaccines*
Coronavirus Infections*/diagnosis
Coronavirus Infections*/prevention & control
Coronavirus Infections*/veterinary
Poultry Diseases*/diagnosis
Poultry Diseases*/prevention & control
Infectious bronchitis virus*/genetics
Bronchitis*
Animals ; Chickens ; Vaccines, Combined ; Real-Time Polymerase Chain Reaction ; Vaccines, Attenuated ; Antibodies, Neutralizing
Czasopismo naukowe
Szczegóły
Tytuł:
Immunoinformatics design of multi-epitope vaccine using OmpA, OmpD and enterotoxin against non-typhoidal salmonellosis.
Autorzy:
Beikzadeh B; Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran. .
Pokaż więcej
Źródło:
BMC bioinformatics [BMC Bioinformatics] 2023 Feb 24; Vol. 24 (1), pp. 63. Date of Electronic Publication: 2023 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Bacterial Vaccines*/chemistry
Bacterial Vaccines*/immunology
Enterotoxins*
Salmonella Infections*/prevention & control
Humans ; Computational Biology ; Epitopes, B-Lymphocyte ; Epitopes, T-Lymphocyte/chemistry ; Escherichia coli ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Vaccines, Subunit/chemistry ; Vaccines, Subunit/immunology
Czasopismo naukowe
Szczegóły
Tytuł:
Comparative frequency of specified adverse events following Vero cell culture-derived Japanese encephalitis and Vi capsular polysaccharide typhoid vaccines in U.S. military personnel, July 2011-August 2019.
Autorzy:
Seshadri S; Immunization Healthcare Division, Public Health Directorate, Defense Health Agency, 7700 Arlington Blvd., Falls Church, VA 22042, USA.
Martin SW; Division of Vector-Borne Diseases, Arboviral Diseases Branch, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO 80521, USA. Electronic address: .
Hills SL; Division of Vector-Borne Diseases, Arboviral Diseases Branch, Centers for Disease Control and Prevention, 3156 Rampart Rd, Fort Collins, CO 80521, USA.
Collins LC Jr; Immunization Healthcare Division, Public Health Directorate, Defense Health Agency, 7700 Arlington Blvd., Falls Church, VA 22042, USA.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2023 Feb 24; Vol. 41 (9), pp. 1537-1540. Date of Electronic Publication: 2023 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Encephalitis, Japanese*/prevention & control
Typhoid-Paratyphoid Vaccines*
Military Personnel*
Japanese Encephalitis Vaccines*
Hypersensitivity*
Animals ; Chlorocebus aethiops ; Mice ; United States ; Humans ; Retrospective Studies ; Vero Cells ; Vaccines, Inactivated ; Polysaccharides ; Cell Culture Techniques
Czasopismo naukowe
Szczegóły
Tytuł:
Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines.
Autorzy:
Boley PA; Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA.
Lee CM; Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA.
Schrock J; Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA.
Yadav KK; Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA.
Patil V; Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA.
Suresh R; Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA.
Lu S; Dynamic Entropy Technology LLC, Building B, 1028 W. Nixon St., Pasco, WA, 99301-5216, USA.
Feng MM; Dynamic Entropy Technology LLC, Building B, 1028 W. Nixon St., Pasco, WA, 99301-5216, USA.
Hanson J; Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA.
Channappanavar R; Department of Veterinary Pathobiology, Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, OK, 74078, USA.
Kenney SP; Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA. .
Renukaradhya GJ; Center for Food Animal Health, Department of Animal Sciences, The Ohio State University, 1680 Madison Avenue, Wooster, OH, 44691, USA. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2023 Feb 22; Vol. 21 (1), pp. 60. Date of Electronic Publication: 2023 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
COVID-19*
Humans ; Animals ; Aged ; Ferrets ; Immunity, Mucosal ; SARS-CoV-2 ; Viral Load ; Antibodies, Viral ; Lung/pathology ; Antibodies, Neutralizing ; Adjuvants, Immunologic ; COVID-19 Vaccines ; mRNA Vaccines
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Szczegóły
Tytuł:
Parental acceptance of and preferences for administration of routine varicella vaccination in the UK: A study to inform policy.
Autorzy:
Sherman SM; School of Psychology, Keele University, Keele ST5 5BG, UK.
Lingley-Heath N; School of Psychology, Keele University, Keele ST5 5BG, UK.
Lai J; Division of Biosciences, University College London, London WC1E 6DE, UK.
Sim J; School of Medicine, Keele University, Keele ST5 5BG, UK.
Bedford H; Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK. Electronic address: .
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2023 Feb 17; Vol. 41 (8), pp. 1438-1446. Date of Electronic Publication: 2023 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Chickenpox*/prevention & control
Viral Vaccines*
Child ; Adult ; Humans ; Male ; Female ; Infant ; Measles-Mumps-Rubella Vaccine ; Cross-Sectional Studies ; Chickenpox Vaccine ; Vaccines, Combined ; Vaccination ; Vaccines, Attenuated ; Parents ; United Kingdom
Czasopismo naukowe
Szczegóły
Tytuł:
Vaccines and Autoimmunity-From Side Effects to ASIA Syndrome.
Autorzy:
Seida I; International School of Medicine, Istanbul Medipol University, 34810 Istanbul, Turkey.
Seida R; International School of Medicine, Istanbul Medipol University, 34810 Istanbul, Turkey.
Elsalti A; International School of Medicine, Istanbul Medipol University, 34810 Istanbul, Turkey.
Mahroum N; International School of Medicine, Istanbul Medipol University, 34810 Istanbul, Turkey.
Pokaż więcej
Źródło:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2023 Feb 14; Vol. 59 (2). Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Autoimmune Diseases*
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Drug-Related Side Effects and Adverse Reactions*
Humans ; Adjuvants, Immunologic/adverse effects ; Autoimmunity ; mRNA Vaccines ; Syndrome ; Vaccines/adverse effects
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 389132

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz